Vibrio cholerae lipopolysaccharide loaded chitosan nanoparticle could save life by induction of specific immunoglobulin isotype

References

• Abdollahi A, Mansouri S, Amani J, Fasihi MR, Moradi M. 2016. Immunoreactivity evaluation of a new recombinant chimeric protein against Brucella in the murine model. Iran J Microbiol. 8:193–202.
   PubMedGoogle Scholar
• Abkar M, Lotfi AS, Amani J, Eskandari K, Ramandi MF, Salimian J, et al. 2015. Survey of Omp19 immunogenicity against Brucella abortus and Brucella melitensis: influence of nanoparticulation versus traditional immunization. Vet Res Commun. 39:217–228.
   PubMed Web of Science ®Google Scholar
• Ahmadi K, Solgue G. 2006. Cytokine pattern in sera and broncho-alveolar lavage six months after single exposer to sulfur mustard. Med J Islam Repub Iran (MJIRI). 20:52–56.
   Google Scholar
• Amini Y, Moradi B, Fasihi-Ramandi M. 2016. Aluminum hydroxide nanoparticles show strong activity to stimulate Th-1 immune response against tuberculosis. Artif Cells Nanomed Biotechnol. 20:1–5.
   Google Scholar
• Amini Y, Tebianian M, Mosavari N, Fasihi Ramandi M, Ebrahimi SM, Najminejad H, et al. 2016. Development of an effective delivery system for intranasal immunization against Mycobacterium tuberculosis ESAT-6 antigen. Artif Cells Nanomed Biotechnol. 28:1–6.
   Google Scholar
• Arthanari S, Mani G, Peng MM, Jang HT. 2016. Chitosan-HPMC-blended microspheres as a vaccine carrier for the delivery of tetanus toxoid. Artif Cells Nanomed Biotechnol. 44:517–523.
   PubMed Web of Science ®Google Scholar
• Bhuiyan TR, Hoq MR, Nishat NS, Al Mahbuba D, Rashu R, Islam K, et al. 2015. Enumeration of Gut-Homing beta7-positive, pathogen-specific antibody-secreting cells in whole blood from enterotoxigenic Escherichia coli- and Vibrio cholerae-infected patients, determined using an enzyme-linked immunosorbent spot assay technique. Clin Vac Immunol. 23:27–36.
   PubMed Web of Science ®Google Scholar
• Boustanshenas M, Bakhshi B, Ghorbani M. 2013. Investigation into immunological responses against a native recombinant CTB whole‐cell Vibrio cholerae vaccine in a rabbit model. J Appl Microbiol. 114:509–515.
   PubMed Web of Science ®Google Scholar
• Chatterjee S, Chaudhuri K. 2006. Lipopolysaccharides of Vibrio cholerae: III. Biological functions. Biochim Biophys Acta (BBA)-Mol Basis Dis. 1762:1–16.
   PubMed Web of Science ®Google Scholar
• De Magistris MT. 2006. Mucosal delivery of vaccine antigens and its advantages in pediatrics. Adv Drug Deliv Rev. 58:52–67.
   PubMed Web of Science ®Google Scholar
• Doavi T, Mousavi SL, Kamali M, Amani J, Fasihi Ramandi M. 2016. Chitosan-based intranasal vaccine against Escherichia coli O157:H7. Iran Biomed J. 20:97–108.
   PubMedGoogle Scholar
• Fasihi-Ramandi M, Amani J, Salmanian A, Moazzeni S, Ahmadi K. 2015. Production and Characterization of new anti-human CD20 monoclonal antibody. Iran J Allergy Asthma Immunol. 14:502–508.
   PubMed Web of Science ®Google Scholar
• Fasihi-Ramandi M, Ghobadi-Ghadikolaee H, Ahmadi-Renani S, Ahmadi K. 2016. Serum anti-Vibrio cholerae immunoglobulin isotype in BALB/c mice immunized with ompW-loaded chitosan. Int J Enteric Pathog. 4:e33137. Epub 2016-05-01.
   Google Scholar
• Fasihi-Ramandi M, Nedjad-Moghaddam A, Arabsalmany F, Asgari S, Ahmadi-Renani S, Ahmadi K. 2014. Production and characterization of monoclonal and polyclonal antibody against recombinant outer membrane protein. Am J Immunol. 10:56–62.
   Google Scholar
• Fournier JM. 1998. The current status of research on a cholera vaccine. Bull Soc Pathol Exot. 91:412–415.
   PubMed Web of Science ®Google Scholar
• Jahantigh DSM, Fasihi Ramandi M, Mousavi M, Zand AM. 2014. Novel intranasal vaccine delivery system by chitosan nanofibrous membrane containing N-terminal region of IpaD antigen as a nasal Shigellosis vaccine, Studies in Guinea pigs. J Drug Deliv Sci Technol. 24:33–39.
   Web of Science ®Google Scholar
• Karlsson SL, Ax E, Nygren E, Kallgard S, Blomquist M, Ekman A, et al. 2014. Development of stable Vibrio cholerae O1 Hikojima type vaccine strains co-expressing the Inaba and Ogawa lipopolysaccharide antigens. PLoS One. 9:e108521.
   PubMed Web of Science ®Google Scholar
• Leung DT, Bhuiyan TR, Nishat NS, Hoq MR, Aktar A, Rahman MA, et al. 2014. Circulating mucosal associated invariant T cells are activated in Vibrio cholerae O1 infection and associated with lipopolysaccharide antibody responses. PLoS Negl Trop Dis. 8:e3076.
   PubMed Web of Science ®Google Scholar
• Leung DT, Uddin T, Xu P, Aktar A, Johnson RA, Rahman MA, et al. 2013. Immune responses to the O-specific polysaccharide antigen in children who received a killed oral cholera vaccine compared to responses following natural cholera infection in Bangladesh. Clin Vac Immunol. 20:780–788.
   PubMed Web of Science ®Google Scholar
• Longini IM Jr, Nizam A, Ali M, Yunus M, Shenvi N, Clemens JD. 2007. Controlling endemic cholera with oral vaccines. PLoS Med. 4:e336.
   PubMed Web of Science ®Google Scholar
• Masuko T, Minami A, Iwasaki N, Majima T, Nishimura S, Lee YC. 2005. Carbohydrate analysis by a phenol–sulfuric acid method in microplate format. Anal Biochem. 339:69–72.
   PubMed Web of Science ®Google Scholar
• Mirnejad R, Jahromi M, Ali M, Al-Musawi S, Pirestani M, Fasihi Ramandi M, et al. 2014. Curcumin-loaded chitosan tripolyphosphate nanoparticles as a safe, natural and effective antibiotic inhibits the infection of Staphylococcus aureus and Pseudomonas aeruginosa in vivo. Iran J Biotechnol. 12:e1012.
   Web of Science ®Google Scholar
• Murugaiah C, Nik Mohd Noor NZ, Mustafa S, Manickam R, Pattabhiraman L. 2014. Construction and evaluation of V. cholerae O139 mutant, VCUSM21P, as a safe live attenuated cholera vaccine. PLoS One. 9:e81817.
   PubMed Web of Science ®Google Scholar
• Onischenko GG, Popova AY, Kutyrev VV, Smirnova NI, Scherbakova SA, Moskvitina EA, et al. 2016. Actual problems of epidemiologic control, laboratory diagnostics and prophylaxis of cholera in Russian Federation. Zh Mikrobiol Epidemiol Immunobiol. 1:89–101.
   Google Scholar
• Pasetti MF, Simon JK, Sztein MB, Levine MM. 2011. Immunology of gut mucosal vaccines. Immunol Rev. 239:125–148.
   PubMed Web of Science ®Google Scholar
• Patel SM, Rahman MA, Mohasin M, Riyadh MA, Leung DT, Alam MM, et al. 2012. Memory B cell responses to Vibrio cholerae O1 lipopolysaccharide are associated with protection against infection from household contacts of patients with cholera in Bangladesh. Clin Vac Immunol. 19:842–848.
   PubMed Web of Science ®Google Scholar
• Pawlowska K, Lodowska J, Jaworska-Kik M, Dzierzewicz Z, Weglarz L, Wilczok T. 2004. Choice of isolation procedure for endotoxins from the outer membrane of the bacteria Desulfovibrio desulfuricans. Med Dosw Mikrobiol. 56:293–300.
   PubMedGoogle Scholar
• Rahman A, Rashu R, Bhuiyan TR, Chowdhury F, Khan AI, Islam K, et al. 2013. Antibody-secreting cell responses after Vibrio cholerae O1 infection and oral cholera vaccination in adults in Bangladesh. Clin Vac Immunol. 20:1592–1598.
   PubMed Web of Science ®Google Scholar
• Rezaei Mokarram A, Alonso M. 2016. Preparation and evaluation of chitosan nanoparticles containing diphtheria toxoid as new carriers for nasal vaccine delivery in mice. Arch Razi Inst. 61:13–25.
   Google Scholar
• Saha A, Khan A, Salma U, Jahan N, Bhuiyan TR, Chowdhury F, et al. 2016. The oral cholera vaccine Shanchol when stored at elevated temperatures maintains the safety and immunogenicity profile in Bangladeshi participants. Vaccine. 34:1551–1558.
   PubMed Web of Science ®Google Scholar
• Sayeed MA, Bufano MK, Xu P, Eckhoff G, Charles RC, Alam MM, et al. 2015. A cholera conjugate vaccine containing O-specific polysaccharide (OSP) of V. cholerae O1 Inaba and recombinant fragment of tetanus toxin heavy chain (OSP:rTTHc) induces serum, memory and lamina proprial responses against OSP and is protective in mice. PLoS Negl Trop Dis. 9:e0003881.
   PubMed Web of Science ®Google Scholar
• Skidmore BJ, Chiller JM, Morrison DC, Weigle WO. 1975. Immunologic properties of bacterial lipopolysaccharide (LPS): correlation between the mitogenic, adjuvant, and immunogenic activities. J Immunol. 114:770–775.
   PubMed Web of Science ®Google Scholar
• Song T, Sun R. 2015. Pharmacodynamics study of zedoary turmeric oil chitosan microspheres administered via arterial embolization. Artif Cells Nanomed Biotechnol. 44:1958–1963.
   PubMed Web of Science ®Google Scholar
• Uddin T, Aktar A, Xu P, Johnson RA, Rahman MA, Leung DT, et al. 2014. Immune responses to O-specific polysaccharide and lipopolysaccharide of Vibrio cholerae O1 Ogawa in adult Bangladeshi recipients of an oral killed cholera vaccine and comparison to responses in patients with cholera. Am J Trop Med Hyg. 90:873–881.
   PubMed Web of Science ®Google Scholar